Kopp, Tamara
Riedl, Elisabeth
Bangert, Christine
Bowman, Edward P.
Greisenegger, Elli
Horowitz, Ann
Kittler, Harald
Blumenschein, Wendy M.
McClanahan, Terrill K.
Marbury, Thomas
Zachariae, Claus
Xu, Danlin
Hou, Xiaoli Shirley
Mehta, Anish
Zandvliet, Anthe S.
Montgomery, Diana
van Aarle, Frank
Khalilieh, Sauzanne
Article History
Received: 23 December 2013
Accepted: 23 December 2014
First Online: 9 March 2015
Change Date: 13 May 2015
Change Type: Correction
Change Details: A second affiliation was added for author T.K. and affiliations were renumbered accordingly.
Competing interests
: T.K. and H.K. and E.R. received research support from Merck & Co., Inc. E.R. received travel support from Merck & Co., Inc., and speaker’s fees, travel support, or served on advisory boards for AbbVie, Novartis, Pfizer, Janssen and Amgen. C.B. received travel support from Merck. C.Z. has served as a scientific consultant for Abbvie, Pfizer, Janssen-Cilag, Merck & Co., Inc., Eli Lilly, Takeda and Novartis and clinical study investigator for AbbVie, Amgen, Eli Lilly, Merck & Co., Inc., Takeda and Novartis. T.M. is an employee of Orlando Clinical Research Center, which was contracted by Merck to conduct the trial. E.P.B., A.H., W.M.B., T.K.M., D.X., X.S.H., A.M., A.S.Z., D.M., F.V.A. and S.K. are current or former employees of Merck & Co., Inc, and may own Merck stock. C.B. and E.G. have no competing interests.